NJ S1365

Prohibits New Jersey pension and annuity funds under the Division of Investment from investing in Chinese pharmaceutical companies or any companies with equity ties or business operations with Chinese pharmaceutical companies

Defines "Chinese pharmaceutical company" as any company headquartered in China that is at least 51% owned and controlled by Chinese citizens, civilian-run enterprises, or the Chinese state government

Requires the State Investment Council and Division of Investment to divest from any prohibited investments within three years of the act's effective date, after consulting with an independent global security risk research firm

Mandates the Division of Investment to file an initial report within 60 days listing all investments violating the act, followed by annual progress reports to the Legislature

Provides indemnification and holds harmless all State Investment Council members and state officers involved in implementing the divestment requirements from any legal claims or damages